Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Malcolm Spicer

Senior Editor, Consumer Health

Washington, DC
Malcolm Spicer is lead analyst for Pharma intelligence | informa's coverage of the consumer health care products industries. He provides comprehensive and insightful reporting on manufacturing, marketing, regulation, legislation, financial and research news about the nonprescription drug and nutritional product industries. He has worked in this post for 10 years and previously reported for other publications on regulation of the health care industry, on the telecommunications and internet technologies and on the US energy market.
Advertisement
Set Alert for Articles By Malcolm Spicer

Latest From Malcolm Spicer

Nurofen Ad 'Headache' Audio Without Visual Makes General Pain Claim

UK advertising regulator says a voice-over in an ad "specifically referenced headache relief" but also stated Nurofen OTC product “acts at the source of pain” as graphics showed the product "acting on non-specific nerves."

Consumer Advertising, Marketing & Sales

Mannatech Makes Hash Of Ingredient Identities In Label, Online Claims

Mannatech crosses FDA line on promoting supplements to treat inflammation and tripped on labeling regulations in differentiating MannaBears and other products, according to a warning letter. A second warning published Nov. 21 noted to contract manufacturer Vita-Pure's ingredient testing problems.

Dietary Supplements Regulation

Medical Food Firm's Production Investigated After Rash Of Adverse Events

FDA receives 194 adverse event reports regarding Primus Pharmaceuticals''s Limbrel medical food capsules, including two about "potentially life-threatening medical conditions." The agency says a likely relation was found between the product and the conditions reported in 30 of the AERs.

United States Ingredients

GAO Report Casts Shade On Sunscreen Ingredients' Chances With FDA

GAO report requested by leadership of House and Senate committees with oversight of FDA adds evidence behind an argument that the agency's monograph process for sunscreen and other OTC ingredients should be changed substantially to facilitate making more pharmaceutical remedies available nonprescription.

Ingredients Regulation

E-Commerce Pricing Pressures 'Manageable' To P&G, But 'Scary' To Analysts

Procter & Gamble says retailer pressure for the firm to lower product pricing to compete with e-commerce and private label is a “real but manageable” problem, while an industry consultant says four megatrends are dictating product prices and changing the way consumers think about consumer health products.

International United States

P&G Board Seat Swings To Peltz In Ongoing Vote Tally

P&G says results from an independent tabulator indicate Trian Fund head Nelson Peltz is leading the firm's candidate, Ernesto Zedillo, in a board proxy vote by around 42,780 shares, or 0.0016% of total outstanding shares. But P&G says the vote count isn't completed.

Consumer Business Strategies
See All
Advertisement
UsernamePublicRestriction

Register